Table 2.
Clinical test results in 114 dogs with degenerative mitral valvular disease according to the modified New York Heart Association (NYHA) functional classification.
| Parameter | NYHA II (n = 38) | NYHA III (n = 46) | NYHA IV (n = 30) |
|---|---|---|---|
| Hb, g/dL | 16.9 ± 2.0 | 14.5 ± 2.8† | 13.8 ± 2.9† |
| Packed cell volume, % | 47.1 ± 5.5 | 39.6 ± 8.1† | 37.8 ± 7.9† |
| RBC count, 106/µL | 7.2 ± 1.0 | 6.1 ± 1.2† | 5.9 ± 1.4† |
| Prevalence of anemia | 0% (0/38) | 15.2% (7/46) | 33.3%† (10/30) |
| Albumin, g/dL | 3.3 ± 0.5 | 3.1 ± 0.5 | 3.1 ± 0.4† |
| BUN, mg/dL | 26.5 ± 15.8 | 37.3 ± 14.9 | 50.8 ± 17.8† |
| CRE, mg/dL | 0.9 ± 0.4 | 1.1 ± 0.6 | 1.4 ± 1.0† |
| Prevalence of azotemia | 34.2% (13/38) | 41.3% (19/46) | 63.3% (19/30) |
| Prevalence of CRE > 1.6 mg/dL | 5.3% (2/38) | 17.4% (8/46) | 23.3%† (7/30) |
| Urine specific gravity | 1.028 ± 0.011 | 1.025 ± 0.012 | 1.023 ± 0.009 |
Data are presented as mean ± SD or % (n).
BUN, blood urea nitrogen; CRE, blood creatinine; Hb, hemoglobin; RBC, red blood cell.
† p < 0.05 versus class II.